{"id":"W2202546386","doi":"10.1016/j.dld.2015.08.015","title":"Boceprevir and peginterferon α-2b plus ribavirin therapy of HCV genotype 3 relapsers: A pilot study","year":2015,"lang":"en","type":"letter","venue":"Digestive and Liver Disease","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Merck Canada Inc. (Canada); University of Calgary","funders":"","keywords":"Boceprevir; Medicine; Ribavirin; Hepatitis C virus; Internal medicine; Hepatitis C; Telaprevir; Virology; Hepatology; Simeprevir; Genotype; Gastroenterology; Virus; Biology; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000293105,0.0004211834,0.0007792405,0.0002652048,0.00007093859,0.00005105023,0.0001724402,0.0001648441,0.0001750461],"category_scores_gemma":[0.0002362589,0.0003439188,0.00008043174,0.0001451966,0.000393513,0.0001330563,0.0002164226,0.001053061,0.00005628339],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001496897,"about_ca_system_score_gemma":0.0005783508,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001096369,"about_ca_topic_score_gemma":0.00003253523,"domain_scores_codex":[0.9974493,0.0003608946,0.0003317309,0.0007150976,0.0007352699,0.0004077412],"domain_scores_gemma":[0.9981883,0.0001827352,0.0001375745,0.0005735084,0.0003761492,0.0005416897],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01084068,0.001697873,0.3777836,0.00125179,0.001128299,0.007603688,0.003757811,7.555124e-7,0.00006168493,0.00001147354,0.5633874,0.03247491],"study_design_scores_gemma":[0.006905928,0.01269975,0.4881268,0.0007377392,0.0006152993,0.000009390838,0.0002200245,0.00008572728,0.000009352339,0.00005079748,0.4899733,0.0005658229],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9172258,0.03575478,0.00001028706,0.03802025,0.0001528802,0.004312106,0.0006425133,0.00007929342,0.003802118],"genre_scores_gemma":[0.9550179,0.007710084,0.00001886912,0.03243589,0.0007997756,0.0001491129,0.000321616,0.0001022931,0.003444476],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1103432,"threshold_uncertainty_score":0.9999013,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09978604887310835,"score_gpt":0.3315938769378718,"score_spread":0.2318078280647634,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}